New Results
Integrative Pharmacogenomics Analysis of Patient Derived Xenografts
Arvind Singh Mer, Wail Ba-alawi, Petr Smirnov, Yi Xiao Wang, Ben Brew, Janosch Ortmann, Ming-Sound Tsao, David Cescon, Anna Goldenberg, Benjamin Haibe-Kains
doi: https://doi.org/10.1101/471227
Arvind Singh Mer
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
2Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
Wail Ba-alawi
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
2Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
Petr Smirnov
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
2Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
Yi Xiao Wang
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
2Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
Ben Brew
3Hospital for Sick Children, Toronto, Ontario, Canada
Janosch Ortmann
4Département de management et technologie, Université du Québec à Montréal, Canada
Ming-Sound Tsao
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
2Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
David Cescon
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
Anna Goldenberg
3Hospital for Sick Children, Toronto, Ontario, Canada
5Department of Computer Science, University of Toronto, Toronto, Ontario, Canada
6Vector Institute, Toronto, Ontario, Canada
Benjamin Haibe-Kains
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
2Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
3Hospital for Sick Children, Toronto, Ontario, Canada
5Department of Computer Science, University of Toronto, Toronto, Ontario, Canada
Article usage
Posted November 16, 2018.
Integrative Pharmacogenomics Analysis of Patient Derived Xenografts
Arvind Singh Mer, Wail Ba-alawi, Petr Smirnov, Yi Xiao Wang, Ben Brew, Janosch Ortmann, Ming-Sound Tsao, David Cescon, Anna Goldenberg, Benjamin Haibe-Kains
bioRxiv 471227; doi: https://doi.org/10.1101/471227
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)